Quantcast
Last updated on April 23, 2014 at 17:29 EDT

Latest Autoimmunity Stories

2013-02-12 08:31:37

PROVIDENCE, R.I., Feb. 12, 2013 /PRNewswire/ -- EpiVax, Inc. is pleased to announce a new Collaborative Research Agreement with Novozymes Biopharma. The collaboration will enable EpiVax to rapidly advance its Tregitope immune-modulating technology as a potential treatment for autoimmune diseases. When used as a buffering agent, albumin has excellent safety and pharmacokinetic profiles. Fusing Tregitopes to Novozymes' proven albumin-based half-life extension platform will create a safe and...

2013-02-07 08:28:15

Richard A. Flavell and Ruslan Medzhitov named co-winners of $100,000 prize Hashim Al-Hashimi, Michael Rape, and Joanna Wysocka win $35,000 Vilcek Prizes for Creative Promise NEW YORK, Feb. 7, 2013 /PRNewswire-USNewswire/ -- The Vilcek Foundation is pleased to name Richard A. Flavell and Ruslan Medzhitov as the co-winners of the 2013 Vilcek Prize for Biomedical Science. Drs. Flavell and Medzhitov, both professors at Yale University School of Medicine and investigators with the Howard...

2013-02-07 08:27:36

INDIANAPOLIS, Feb. 7, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) announced today that it will discontinue the Phase 3 rheumatoid arthritis (RA) program for tabalumab, an anti-BAFF (B cell activating factor) monoclonal antibody, due to lack of efficacy. The decision was not based on safety concerns. The tabalumab Phase 3 program for systemic lupus erythematosus, ILLUMINATE, is ongoing and will continue as planned. In December 2012, Lilly discontinued the Phase 3 RA registration...

2013-02-07 08:27:06

SEATTLE, Feb. 7, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced data from toxicology studies evaluating OMS721, the lead human monoclonal antibody in Omeros' mannan-binding lectin associated serine protease-2 (MASP-2) program. Based on the data from these nonhuman primate studies, OMS721 is expected to be delivered subcutaneously to patients at a convenient dosing schedule of weekly, bi-monthly or even less frequently. Omeros is now analyzing additional data and...

2013-02-06 12:26:13

NEW YORK, Feb. 6, 2013 /PRNewswire/ -- The Lupus Research Institute (LRI), the world's leading supporter of innovative research in lupus, invites notable scientists from around the world to submit proposals for $1 million Distinguished Innovator Awards. Selection will be based on originality and potential to uncover the fundamental causes of autoimmunity in lupus that can propel toward a cure. Launched just a year ago as the first $1 million private sector lupus research grants, the...

Looking For The Key To Immunity
2013-02-04 13:35:50

ESA [ Watch The Video ] Living in space weakens astronauts´ immune systems, researchers have discovered. The findings are providing clues on how to tackle diseases on Earth before symptoms appear. Ever since the first humans ventured into space we have known that astronauts can suffer from common infections that would be quickly dealt with by healthy people on Earth. Until now, it was not clear what was blocking astronauts´ immune systems from working normally. In 2006,...

2013-02-04 10:28:23

Scientists have identified the gene essential for survival of antibody-producing cells, a finding that could lead to better treatments for diseases where these cells are out of control, such as myeloma and chronic immune disorders. The discovery that a gene called Mcl-1 is critical for keeping this vital immune cell population alive was made by researchers at Melbourne's Walter and Eliza Hall Institute. Associate Professor David Tarlinton, Dr Victor Peperzak and Dr Ingela Vikstrom from the...

2013-01-31 12:28:53

NEW YORK, Jan. 31, 2013 /PRNewswire/ -- The Lupus Research Institute (LRI) - world's leading supporter of innovative research in lupus -- today awards $3.6 million in Novel Research Grants to allow 12 investigators to pursue ground-breaking studies with potential for transformative results. The $300,000 grants provide scientists with the resources to devote their talent to lupus research for three years. In just its first decade of service, the LRI has awarded more than $40 million for novel...

2013-01-31 12:28:04

GLEN ALLEN, Va., Jan. 31, 2013 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: STSI) today announces publication of the first peer-reviewed article examining the effects of anatabine in a mouse model of the debilitating autoimmune and neurodegenerative disease multiple sclerosis (MS). The study, conducted by the Company's research partner, The Roskamp Institute, was designed to determine whether anatabine had beneficial effects on the development of experimental autoimmune encephalomyelitis...

2013-01-29 08:30:18

LEIDEN, The Netherlands and SAN DIEGO, Jan. 29, 2013 /PRNewswire/ -- Leiden University Medical Center (LUMC) and INOVA Diagnostics are pleased to announce the completion of an exclusive, worldwide license agreement for technology developed at LUMC to detect antibodies to carbamylated proteins (anti-CarP). This technology represents an important advance in the diagnosis of Rheumatoid Arthritis (RA). "The detection of autoantibodies in sera of RA patients has provided important insight into...